Initial Prednisolone Weaning in Nephrotic Syndrome: adrenal suppression and its association with relapse

Phase 3

• Conditions: Childhood Idiopathic Nephrotic Syndrome; Adrenal gland suppression; Renal and Urogenital - Kidney disease; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12621001428853
• Lead Sponsor: Dr Amelia Le Page

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-21
• Last Update Posted: 8 November 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Age 2-<16 years
First episode of idiopathic nephrotic syndrome

Exclusion Criteria

Past or current pituitary or adrenal disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified